Science Sun Pharm(300485.SZ)

Last Updated 00:00:00
longbridge loading

Science Sun Pharm: Net profit in the third quarter was 4.0733 million yuan, a decrease of 41.41%

Zhitong·
SZ
300485
-5.49%
Zhitong·
SZ
300485
-5.49%

Science Sun Pharm shareholders Ma Li and Liu Shuqin plan to collectively reduce their holdings by no more than 2%

Zhitong·
SZ
300485
-5.49%
Zhitong·
SZ
300485
-5.49%

Science Sun Pharm: In the first half of 2025, net profit was 47.7862 million yuan, a year-on-year increase of 145.45%

Zhitong·
SZ
300485
-5.49%
Zhitong·
SZ
300485
-5.49%

China Science Sun Pharm is in talks to authorize weight loss drugs in the United States. (Reuters)

Wallstreetcn·
SZ
300485
-5.49%
Wallstreetcn·
SZ
300485
-5.49%

The monoclonal antibody concept was active at the beginning of the trading session, with Science Sun Pharm and HAINAN HAIYAO both rising over 9%, while YILING PHARMACEUTICAL, Zhongyuan Union, and FUDANZHANGJIANG also saw gains

Zhitong·
SH
688505
-1.03%
HK
01349
-1.14%
SZ
300485
-5.49%
Zhitong·
SH
688505
-1.03%
HK
01349
-1.14%
SZ
300485
-5.49%

Innovative drug concept stocks are repeatedly active, Thalys has three consecutive limit-ups

Zhitong·
SZ
300485
-5.49%
SH
603716
-1.20%
SH
688520
+1.31%
Zhitong·
SZ
300485
-5.49%
SH
603716
-1.20%
SH
688520
+1.31%

The biopharmaceutical sector continues to adjust, with *ST Four Rings hitting the daily limit down, Rongchang Bio falling over 18%, and Mabwell, SDKX, Science Sun Pharm, OPM, Aidea Pharma, and others following suit

Zhitong·
SH
688293
-3.31%
SH
688488
-1.25%
SZ
300485
-5.49%
Zhitong·
SH
688293
-3.31%
SH
688488
-1.25%
SZ
300485
-5.49%

"Shanghai and Shenzhen" bank stocks support the Shanghai Composite Index to stabilize slightly in the first half of the day, while oil and gold stocks are weak, and innovative drug concept stocks rise

AASTOCKS·
SH
601398
+0.28%
HK
01398
-1.16%
US
CICHY
-0.25%
AASTOCKS·
SH
601398
+0.28%
HK
01398
-1.16%
US
CICHY
-0.25%

Science Sun Pharm signed a transfer contract with BGI Protein regarding the NeoAB33 new drug project related technology

Zhitong·
SZ
300485
-5.49%
Zhitong·
SZ
300485
-5.49%

Science Sun Pharm released its first-quarter performance, with a net profit attributable to the parent company of 39.97 million yuan

Zhitong·
SZ
300485
-5.49%
Zhitong·
SZ
300485
-5.49%
© 2026 Longbridge｜Disclaimer